Profile data is unavailable for this security.
About the company
Beijing Konruns Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research and development, production and sales of drugs. The Company's main product Suling belongs to the haemocoagulase drug that activates the coagulation process, which is mainly used for hemostasis of superficial wound bleeding in surgical operations as well as the bleeding caused by postoperative, trauma and disease. The Company’s present products under research include a range of innovative and generic drugs for tumors and blood. The Company mainly distributes its products in the domestic market.
- Revenue in CNY (TTM)846.29m
- Net income in CNY114.79m
- Incorporated2003
- Employees447.00
- LocationBeijing Konruns Pharmaceutical Co LtdNo. 3 Building, No. 7 YardKexueyuan Road, Zhongguancun LifeScience Park, Changping DistrictBEIJING 102206ChinaCHN
- Phone+86 1 082898898
- Fax+86 1 082898886
- Websitehttp://www.konruns.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Obio Technology Shanghai Corp Ltd | 251.68m | -246.61m | 3.63bn | 731.00 | -- | 1.94 | -- | 14.41 | -0.3834 | -0.3834 | 0.3915 | 2.89 | 0.1012 | 4.00 | 2.55 | 344,293.00 | -9.93 | 0.2246 | -11.17 | 0.2514 | -26.42 | 36.72 | -98.16 | 1.48 | 2.27 | -- | 0.104 | 0.00 | -29.69 | 35.88 | -425.90 | -- | 57.00 | -- |
| Hunan Warrant Pharmaceutical Co Ltd | 1.45bn | 211.45m | 3.70bn | 1.16k | 17.49 | 1.96 | -- | 2.56 | 2.25 | 2.25 | 15.42 | 20.06 | 0.6426 | 1.49 | 9.74 | 1,244,707.00 | 8.34 | 11.21 | 9.79 | 14.05 | 61.32 | 69.00 | 12.98 | 13.96 | 3.18 | -- | 0.0566 | 8.05 | 10.84 | 18.50 | 15.60 | 19.02 | 24.49 | -- |
| Beijing Konruns Pharmaceutical Co Ltd | 846.29m | 114.79m | 3.80bn | 447.00 | 32.48 | 1.19 | -- | 4.49 | 0.7311 | 0.7311 | 5.38 | 20.03 | 0.2178 | 1.95 | 2.90 | 1,893,258.00 | 3.81 | 5.43 | 4.48 | 6.24 | 87.83 | 89.93 | 17.52 | 20.76 | 3.36 | -- | 0.0582 | 21.53 | 6.15 | -2.08 | 48.24 | -10.63 | 43.05 | -9.71 |
| Jiangsu Aidea Pharmaceutical Co Ltd | 408.68m | -104.55m | 3.88bn | 476.00 | -- | 3.62 | -- | 9.48 | -0.2384 | -0.2384 | 0.9459 | 2.54 | 0.2193 | 0.9553 | 2.66 | 858,576.30 | -5.65 | -2.40 | -8.32 | -2.85 | 48.96 | 39.00 | -25.77 | -10.15 | 1.11 | -- | 0.3018 | -- | 68.44 | 8.24 | 38.75 | -- | -4.47 | -- |
| Shanghai Fudan Forward S&T Co Ltd | 638.98m | -15.28m | 3.91bn | 1.36k | -- | 5.06 | -- | 6.12 | -0.0222 | -0.0222 | 0.9345 | 1.13 | 0.3799 | 0.6476 | 8.53 | 468,807.20 | -0.9863 | -0.8781 | -1.68 | -1.53 | 36.63 | 43.22 | -2.60 | -1.85 | 0.413 | -2.40 | 0.3319 | -- | -13.86 | -7.58 | 196.17 | -32.57 | -13.88 | -- |
| Shanghai Shenqi Pharmactcl Inv Mgt CoLtd | 2.19bn | 50.41m | 3.91bn | 1.43k | 81.27 | 1.74 | -- | 1.78 | 0.0944 | 0.0944 | 4.11 | 4.41 | 0.6831 | 4.89 | 5.41 | 1,538,342.00 | 1.61 | -0.6002 | 2.02 | -0.7417 | 46.46 | 56.64 | 2.35 | -0.9128 | 2.46 | 23.86 | 0.0908 | -- | -2.00 | 4.79 | 17.41 | -11.68 | -25.97 | -- |
| Zhejiang Starry Pharmaceutical Co Ltd | 2.37bn | 13.89m | 4.02bn | 1.85k | 182.40 | 1.51 | -- | 1.69 | 0.0502 | 0.0502 | 5.72 | 6.08 | 0.4094 | 1.74 | 6.76 | 1,284,337.00 | 0.2471 | 3.30 | 0.4806 | 5.97 | 21.35 | 32.35 | 0.6036 | 8.21 | 0.4855 | 1.21 | 0.4994 | 53.08 | 3.04 | 19.78 | 158.32 | -13.94 | 10.39 | -- |
Data as of Nov 05 2024. Currency figures normalised to Beijing Konruns Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
7.68%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| CITIC Securities Co., Ltd. (Invt Port)as of 30 Jun 2024 | 6.74m | 4.28% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 1.44m | 0.91% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 2024 | 1.41m | 0.89% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2024 | 1.04m | 0.66% |
| Cinda Fund Management Co. Ltd.as of 30 Jun 2024 | 381.60k | 0.24% |
| China International Capital Corp. HK Asset Management Ltd.as of 30 Jun 2024 | 370.90k | 0.24% |
| Goldstate Capital Fund Management Co., Ltd.as of 30 Jun 2024 | 369.70k | 0.23% |
| Nuode Asset Management Co., Ltd.as of 30 Jun 2024 | 132.80k | 0.08% |
| Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 30 Jun 2024 | 131.18k | 0.08% |
| Dongxing Asset Management Co. Ltd.as of 30 Jun 2024 | 104.40k | 0.07% |
More ▼
Data from 30 Jun 2024 - 29 Oct 2024Source: FactSet Research Systems Inc.
